CAR-T Targeting Igβ Targets
/ The First Affiliated Hospital of Soochow University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 05, 2022
Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma
(clinicaltrials.gov)
- P2 | N=12 | Recruiting | Sponsor: The First Affiliated Hospital of Soochow University
CAR T-Cell Therapy • New P2 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1